GGrantIndex
← Search

Community Outreach and Engagement

$92,459P30FY2023CANIH

Wake Forest University Health Sciences, Winston-Salem NC

Investigators

Linked publications, trials & patents

Trial NCT07614022Trial NCT07324577Trial NCT07322367Trial NCT07282444Trial NCT07203534Trial NCT07196241Trial NCT07175376Trial NCT07119489Trial NCT07046936Trial NCT06945042Trial NCT06709404Trial NCT06654245Trial NCT06480591Trial NCT06441266Trial NCT06340503Trial NCT05984680Trial NCT05934851Trial NCT05877404Trial NCT05854966Trial NCT05825066Trial NCT05796518Trial NCT05696782Trial NCT05692635Trial NCT05597878Trial NCT05395936Trial NCT05309655Trial NCT05242770Trial NCT05212272Trial NCT05204290Trial NCT05030038Trial NCT04897217Trial NCT04858269Trial NCT04797884Trial NCT04677816Trial NCT04659993Trial NCT04623515Trial NCT04586127Trial NCT04526080Trial NCT04495751Trial NCT04485026Trial NCT04454489Trial NCT04430335Trial NCT04415944Trial NCT04375384Trial NCT04337580Trial NCT04327700Trial NCT04266470Trial NCT04253964Trial NCT04217317Trial NCT04174742Trial NCT04173247Trial NCT04111107Trial NCT04040244Trial NCT04037527Trial NCT03998189Trial NCT03987568Trial NCT03987555Trial NCT03982537Trial NCT03963739Trial NCT03958747Trial NCT03929211Trial NCT03890614Trial NCT03880526Trial NCT03874065Trial NCT03870529Trial NCT03870451Trial NCT03868943Trial NCT03867175Trial NCT03861091Trial NCT03861065Trial NCT03796273Trial NCT03746262Trial NCT03741868Trial NCT03741829Trial NCT03740035Trial NCT03681405Trial NCT03662074Trial NCT03529565Trial NCT03520283Trial NCT03505762Trial NCT03505736Trial NCT03505671Trial NCT03379376Trial NCT03374995Trial NCT03370159Trial NCT03188432Trial NCT03152786Trial NCT03148080Trial NCT03139435Trial NCT03122743Trial NCT03087591Trial NCT03032250Trial NCT02971410Trial NCT02971397Trial NCT02949843Trial NCT02835222Trial NCT02835066Trial NCT02832154Trial NCT02827838Trial NCT02747407

Abstract

COMMUNITY OUTREACH AND ENGAGEMENT (COE): PROJECT SUMMARY The Wake Forest Baptist Comprehensive Cancer Center (WFBCCC) serves a 58-county region in western North Carolina, southwestern Virginia, and southern West Virginia. This catchment area is largely rural and has significant racial, ethnic, and geographic cancer disparities, driven largely by elevated cancer risk factors (obesity, tobacco use) and limited access to health care and other socia l determinants of health in the region. The overall goal of Community Outreach and Engagement (COE) at WFBCCC is to inform research, develop education programs, and implement cancer control strategies to address the cancer burden within the WFBCCC catchment area, with a particular focus on cancers that disproportionately impact the region. The COE seeks to achieve the following Specific Aims: (1) define, describe, and disseminate information on the cancer burden, risk factors, and disparities in the catchment area to guide WFBCCC research and community-informed interventions; (2) implement evidence-based cancer control interventions, facilitated through community collaborations and designed to impact the burden of cancer in the catchment area; (3) facilitate and support community-engaged research and diverse and inclusive clinical trial participation within the Cancer Center, region, and beyond; and (4) promote policy and advocacy directed at reducing the cancer burden and disparities and advancing cancer health equity. COE activities are facilitated through the Office of Cancer Health Equity (OCHE), led by Ronny Bell, PhD, MS, (Director) and assisted by Kathryn Weaver, PhD, MPH, (Assistant Director, Research Integration), and Carla Strom, MLA (Assistant Director, Operations). The COE staff reflects the diversity of the catchment area and includes Population Health Navigators, Community Educators, and Research Facilitators. Bell receives guidance and input from the Community Advisory Board, which ensures integration of community engagement into the clinical, research, and educational activities of the WFBCCC. The COE uses the COE Internal Steering Committee to coordinate research and training activities across WFBCCC Programs. The COE has been very successful in increasing participation of underserved populations in cancer clinical trials. For example, the year prior to the start of the Underserved Patient Navigation Program, 20% of Hispanic patients participated in interventional studies. Among navigated patients, the participation rate increased from 14% to 34%. To ensure that COE achieves its mission, COE effectiveness will be assessed through monitoring: (1) research addressing catchment needs and disparities; (2) minority participation in research; (3) awareness and knowledge of cancer prevention and control strategies; and, (4) access to culturally appropriate cancer-related care. Future directions for the COE will focus on expanding data collection activities through enhanced analytic tools; developing collaborations outside North Carolina; forming collaborative relationships through the new strategic alliance between Wake Forest Baptist Health and Atrium Health ; and working toward local, state, and national policies focused on eliminating cancer disparities.

View original record on NIH RePORTER →